Hepatitis C infection has been declared a global health problem. Prevalence is most common among injecting drug user populations, where up to 98% can be infected despite a low HIV prevalence. Up to 20% of those infected with hepatitis C can clear the virus, though chronic infection can lead to significant hepatic morbidity and death.